Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
4.750
-0.130 (-2.66%)
At close: Aug 12, 2026, 4:00 PM EDT
4.700
-0.050 (-1.05%)
After-hours: Aug 12, 2026, 7:03 PM EDT
Embecta Employees
Embecta had 1,850 employees as of September 30, 2025. The number of employees decreased by 250 or -11.90% compared to the previous year.
Employees
1,850
Change (1Y)
-250
Growth (1Y)
-11.90%
Revenue / Employee
$550,649
Profits / Employee
$47,297
Market Cap
269.13M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 1,850 | -250 | -11.90% |
| Sep 30, 2024 | 2,100 | -100 | -4.55% |
| Sep 30, 2023 | 2,200 | 300 | 15.79% |
| Sep 30, 2022 | 1,900 | -129 | -6.36% |
| Sep 30, 2021 | 2,029 | -298 | -12.81% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AngioDynamics | 632 |
| OraSure Technologies | 500 |
| Pro-Dex | 181 |
| Anteris Technologies Global | 174 |
| Nyxoah | 154 |
| Utah Medical Products | 152 |
| Stereotaxis | 131 |
| Sanara MedTech | 108 |
EMBC News
- 9 hours ago - Kaplan Fox Reminds Embecta Corp. (NASDAQ: EMBC) Investors with Significant Losses to Seek a Leadership Role Before Deadline on August 17, 2026 - GlobeNewsWire
- 12 hours ago - Kaplan Fox Notifies Embecta Corp. (EMBC) Investors of an Upcoming Lead Plaintiff Deadline on August 17, 2026 - Newsfile Corp
- 1 day ago - EMBC Investor Announcement: Embecta Sued on behalf of Investors to Recover Losses after Insulin Pen Issues Lead to 57% Stock Drop - PRNewsWire
- 5 days ago - Kaplan Fox Notifies Embecta Corp. (EMBC) Investors of an Upcoming Lead Plaintiff Deadline on August 17, 2026 - Newsfile Corp
- 5 days ago - Embecta Earnings Call Transcript: Q3 2026 - Transcripts
- 5 days ago - Embecta Earnings release: Q3 2026 - Filings
- 5 days ago - Embecta Slides: Q3 2026 - Filings
- 5 days ago - Embecta Quarterly report: Q3 2026 - Filings